| CCCRX | VFFSX | CCCRX / VFFSX | |
| Total Expense Ratio | 1.24 | 0.01 | 12,400% |
| Annual Report Gross Expense Ratio | 1.24 | 0.01 | 12,400% |
| Fund Existence | 15 years | 10 years | - |
| Gain YTD | 10.117 | 17.891 | 57% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.3B | 1.48T | 1% |
| Annual Yield % from dividends | 0.07 | 1.13 | 6% |
| Returns for 1 year | 7.24 | 14.87 | 49% |
| Returns for 3 years | 59.76 | 81.45 | 73% |
| Returns for 5 years | 29.10 | 87.59 | 33% |
| Returns for 10 years | 83.15 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUSA | 37.17 | 0.07 | +0.19% |
| Brandes U.S. Value ETF | |||
| VCRM | 75.47 | 0.04 | +0.05% |
| Vanguard Core Tax-Exempt Bond ETF | |||
| CGMM | 29.47 | -0.07 | -0.24% |
| Capital Group U.S. Small & Mid Cap ETF | |||
| FBT | 214.13 | -0.93 | -0.43% |
| First Trust NYSE Arca Biotech ETF | |||
| QIS | 15.31 | -0.11 | -0.73% |
| Simplify Multi-QIS Alternative ETF | |||